Profacgen news
Profacgen, a leading provider of custom biotechnology services, is pleased to announce significant updates to its Antimicrobial Peptides (AMPs) Services, enhancing its capabilities to support the growing demand for alternative therapies in the fight against drug-resistant pathogens.
As antibiotic resistance continues to pose a global health threat, Profacgen is expanding its services to assist researchers, pharmaceutical companies, and healthcare providers in developing n
Profacgen, one of the leading biotechnology companies that provides first-class protein expression services, recently announced the release of multi-protein expression service in insect cells, to help scientists conduct protein co-expression network analysis and interaction studies.
Multiprotein complexes are involved in a wide range of cellular processes, including transcription
Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers.
Profacgen has recently updated its E3 Ligase and Target Proteins Development Services, expanding the company’s portfolio of PROTAC development services. The updated services provide scientists with comprehensive advanced platform for their projects.
The ubiquitin proteasome system relies heavily on E3 ligases (UPS). As a major modulator of protein homeostasis, UPS is essential in signal transduction, mitophagy, DNA damage repair, inflammatory pathways,
Profacgen, an experienced provider in biological research and drug discovery, provides various ubiquitin services to help customers accelerate research progress and obtain better results.
Ubiquitination is one of the most prevalent post-translational modifications (PTMs) in cells. Ubiquitin modification induces protein degradation, which affects the function, localization, and activity of proteins. Therefore, the study of
Profacgen, a state-of-the-art protein service provider located in the USA, provides comprehensive one-stop services for pre-clinical drug development, aiming to evaluate and improve the efficacy and safety of new drug candidates. Now, Profacgen can provide soluble Fc fusion protein to applicate in various fields.
Fc fusion protein refers to a new type of protein produced by using genetic engi
Profacgen, a state-of-the-art protein service provider located in the USA that provides custom protein services in biological sciences, recently launched a new and highly effective antibiotic-free expression system to meet scientists’ needs in the protein expression field.
Expression vectors inserted with antibiotic resistance genes are mai
Profacgen, a state-of-the-art protein service provider that provides custom protein services in the biological sciences, recently updated its membrane protein modeling service to better assist scientists in the field of structure-based protein engineering.
Membrane proteins account for one third of all genes in the human genome, and they play critical roles as receptors, enzymes, ion channels, and trans
Profacgen, a global provider of drug screening and profiling services that offers a comprehensive panel of services designed to speed and simplify drug discovery research, now offers professional high-throughput GPCR screening services for identification of potential GPCR-targeting drugs.
G protein-coupled receptors (GPCRs) are also known as seven-transmembrane domain receptors. They are present only
Profacgen, a US-based biotechnology company, recognizing the importance of computational technologies for pursuing advanced research in modern biology, released custom bioinformatics software development to offer support for both academic and industrial researchers to explore, understand and analyze complex biological data in a variety of biotechnology programs and projects.
Bioinf